Chandra Bhagat Pharma Limited (BOM:542934)
39.36
+1.86 (4.96%)
At close: Aug 4, 2026
Chandra Bhagat Pharma Market Cap
Chandra Bhagat Pharma has a market cap or net worth of 296.97 million as of August 5, 2026. Its market cap has decreased by -28.44% in one year.
Market Cap
296.97M
Enterprise Value
414.25M
Revenue
1.16B
Ranking
n/a
PE Ratio
9.74
Stock Price
39.36
ChartMarket Cap Chart
Since February 14, 2020, Chandra Bhagat Pharma's market cap has decreased from 390.46M to 296.97M, a decrease of -23.94%. That is a compound annual growth rate of -4.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 296.97M | -4.58% |
| Dec 31, 2025 | 311.23M | -37.19% |
| Dec 31, 2024 | 495.48M | -43.90% |
| Dec 28, 2023 | 883.15M | 3.58% |
| Dec 27, 2022 | 852.59M | 25.56% |
| Dec 29, 2021 | 679.06M | 100.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Constronics Infra | 636.48M |
| Goldline Pharmaceutical | 395.52M |
| Medistep Healthcare | 272.82M |
| Medico Intercontinental | 250.00M |
| Pentokey Organy (India) | 219.86M |
| Centuple Global | 187.34M |
| Zenlabs Ethica | 185.47M |
| Muller & Phipps (India) | 136.25M |